Combined treatment of dendritoma vaccine and low-dose interleukin-2 in stage IV renal cell carcinoma patients induced clinical response: A pilot study.

Source:http://linkedlifedata.com/resource/pubmed/id/17671717

Download in:

View as

General Info

PMID
17671717